Warsaw - Delayed Quote PLN
Genomtec S.A. (GMT.WA)
7.25
+0.05
+(0.69%)
At close: 4:10:17 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1
1
40
219
20
Cost of Revenue
1,199
794
3,271
5,381
3,528
Gross Profit
-1,198
-793
-3,231
-5,162
-3,508
Operating Expense
10,237
8,313
8,107
5,002
7,355
Operating Income
-11,435
-9,106
-11,338
-10,164
-10,863
Net Non Operating Interest Income Expense
-36
-172
-292
-28
-15
Pretax Income
-11,458
-9,031
-11,882
-7,110
-10,935
Tax Provision
118
-18
46
5
4
Net Income Common Stockholders
-11,576
-9,013
-11,928
-7,115
-10,939
Diluted NI Available to Com Stockholders
-11,576
-9,013
-11,928
-7,115
-10,939
Basic EPS
-0.87
-0.74
-1.27
-0.87
-1.34
Diluted EPS
-0.87
-0.74
-1.27
-0.87
-1.34
Basic Average Shares
12,979.74
12,179.73
9,392.13
8,178.16
8,158.54
Diluted Average Shares
12,979.74
12,179.73
9,392.13
8,178.16
8,158.54
Total Operating Income as Reported
-11,350
-8,727
-11,492
-6,995
-1,767.23
Total Expenses
11,436
9,107
11,378
10,383
10,883
Net Income from Continuing & Discontinued Operation
-11,576
-9,013
-11,928
-7,115
-10,939
Normalized Income
-11,593.01
-9,100.82
-11,803.26
-7,102.04
-10,939
Interest Income
76
64
0
0
3
Interest Expense
110
119
201
28
18
Net Interest Income
-36
-172
-292
-28
-15
EBIT
-11,348
-8,912
-11,681
-7,082
-10,917
EBITDA
-8,987
-7,756
-11,245
-6,578
-10,673
Reconciled Cost of Revenue
1,199
794
3,271
5,381
3,528
Reconciled Depreciation
2,361
1,156
436
504
244
Net Income from Continuing Operation Net Minority Interest
-11,576
-9,013
-11,928
-7,115
-10,939
Total Unusual Items Excluding Goodwill
21
88
-154
-16
--
Total Unusual Items
21
88
-154
-16
--
Normalized EBITDA
-9,008
-7,844
-11,091
-6,562
-10,673
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
3.99
0.18
-29.26
-3.04
0
12/31/2020 - 3/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade